The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: UK MIDDAY BRIEFING: Unilever Kicks Off New Earnings Season

Tue, 21st Jan 2014 13:03

(An item published at 1259 GMT misstated the market prices. The correct version follows.)

LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant Unilever Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and whole of 2013, but its earnings beat expectations as margins were supported by price increases and cost cutting.

The company said it is facing increased competition in its still-weak developed markets, while growth has moderated in emerging markets, a reality that Chief Executive Paul Polman says the company now has to just "deal with". While its personal care brands, like Dove, are doing well, sales of its refreshment brands and some of its food brands, like its spreads, fell.

Warning that competition will remain fierce in 2014, Polman pledged to stay focused on raising margins, even though it will invest in re-invigorating its stalled food business.

Unilever was joined by the likes of SABMiller, PZ Cussons and digital media company Next Fifteen Communications Group in warning that recent currency moves were weighing on earnings.

Brewing giant SABMiller reported higher sales for its fiscal third quarter that met analysts' expectations, as volumes rose and it managed to raise prices. Growth continued to be driven by emerging markets like Africa, Latin America and China. However, "depreciation of key currencies against the US dollar will adversely impact reported results," it warned.

Unilever's 2013 operating profit came in at EUR7.51 billion, up 8% from EUR7.0 billion in 2012. However, it said the increase would have been 15% is currencies had stayed constant during the year.

Next Fifteen, meanwhile, said the current strength of sterling against both the US dollar and the Euro will hold back its revenues and profits, even though trading was off to a strong start in the financial year.

In economic news, British Chancellor of the Exchequer George Osborne will be eagerly awaiting the latest growth forecasts from the International Monetary Fund later Tuesday. The fund is widely reported to be about to raise its forecasts for UK growth more than for any other major economy.

The United Nations Tuesday predicted that the world economy will grow 3% this year and 3.3% in 2015, after growth of 2.1% in 2012.

Backing the growth forecasts, the International Energy Agency nudged up its global oil demand growth forecast for 2014, citing demand strength. It moved up its global oil demand forecast by 1.3 million barrels a day, after reporting stronger-than-expected demand in the fourth quarter of last year.

In the UK, the value of mortgages disbursed by UK banks remained broadly stable in December from the previous month, figures released by the Council for Mortgage Lenders revealed. The total value of mortgage lending was GBP17 billion in December, up 49% on the same month in 2012 and the highest for that month since December 2007.

Meanwhile, British manufacturing order growth during three months to January hit the highest since April 2011, survey data from the Confederation of British Industry showed Tuesday.

Elsewhere, The Thai government has declared a 60-day state of emergency in Bangkok and parts of nearby province, after almost 80 days of anti-government protests in the capital that have taken a more violent turn in recent days, media reports in the country say.

Protests in Ukraine capital Kiev also continued overnight, when hundreds of radical opposition supporters pelted police with Molotov cocktails and cobblestones. Opposition leader and former boxing champion Vitaly Klitschko warned protesters that the government was sending paid thugs to destabilise the situation.

Iran may be taking steps to limit its nuclear programme, but that doesn't mean it's in step with the majority of the international community on regional issues. UN Secretary General Ban Ki-moon has revoked his invitation for Tehran to attend Wednesday's Syrian peace conference, saying Iranian officials had failed to support the goals of the international talks.

--------

FTSE 100: Up 0.1% at 6,845.85
FTSE 250: Down 0.3% at 16,183.93
AIM ALL-SHARE: Down 0.1% at 881.32
GBP-USD: 1.6431
EUR-USD: 1.3529
GOLD: USD1,243.90 an ounce
OIL (Brent): USD107.71 a barrel

--------

KEY UK CORPORATE NEWS:

FTSE 100: IMI is proposing to return GBP620 million, or 200 pence a share, to shareholders from proceeds of the disposal of its Beverage Dispense and Merchandising division. Melrose Industries, meanwhile, said it plans to use part of the proceeds from FKI business disposals to return about GBP600 million to shareholders, after using some of the proceeds to pay down borrowings. GlaxoSmithKline's joint venture Viiv Healthcare Ltd has had its Tivicay integrase inhibitor approved for use in combination with other anti-retroviral medicinal products for the treatment of HIV by the European Commission.

FTSE 250: African Barrick Gold has exceeded its initial 2013 gold production guidance and continued its cost cutting. Gold production of 641,931 ounces was 3% higher than in 2012 and significantly exceeded guidance of between 540,000 and 600,000 ounces. Its preliminary fourth quarter all-in sustaining cost was USD1,171 per ounce of gold sold, down 30% on the previous year and 8% on the previous quarter. Polymetal International produced 1.3 million ounces of gold equivalent in 2013, a 21% increase on the previous year and above its production guidance of 1.2 million ounces. Cairn Energy plans to drill nine wells in its 2014 exploration programme across a mix of different areas. John Wood Group has secured two major contract extensions in Africa worth USD250 million. Carphone Warehouse has reiterated its full-year guidance after it saw 3.1% like-for-like revenue growth in its fiscal third quarter and encouraging progress on its sales of 4G services. Like-for-like sales were up 5% in the UK. Marston's says trading in the financial year to date has been "encouraging", with profitability in line with expectations, boosted by good trading over the Christmas and New Year period. The brewer also said that it achieved like-for-like sales growth across is business estate. PZ Cussons said revenue for the half-year was up 4.1%, in line with management expectations, as it boosted its interim dividend to 2.53 pence per share. Restaurant Group has started searching for a replacement for Chief Executive Officer Andrew Page, who will retire in August. Intermediate Capital Group said it raised EUR1.1 billion of new third-party money in the third quarter, lifting nine-month gross inflows above the full previous year. Petra Diamonds has found an "exceptional" 29.6 carat blue diamond at its Cullinan mine in South Africa.

AIM: Rose Petroleum is a big gainer after it completed the previously announced acquisition of two fracking licences in Germany. The company said it has purchased the entire share capital of Parkyn Energy Holdings PLC, which owns 100% of the German licences through its subsidiary Parkyn Energy Germany Ltd, for EUR400,000. Pressure Technologies is doing well after its alternative energy division, Chesterfield BioGas, was awarded a GBP4.2 million contract to upgrade biogas supply equipment to the UK energy grid, and is also in advanced talks on potential further deals. IQE is another gainer as it said it expects to report 2013 revenue of at least GBP126.0 million, up 43% from GBP88.0 million in 2012. The company also expects Ebitda of at least GBP24.5 million, up 49% from GBP16.4 million in 2012, as it improved its operational efficiency. Touchstone Gold is a big faller after it warned that if it cannot find additional funding it will not be able to meet scheduled payments to vendors of its concession contracts. Touchstone also said it has managed to enter into an agreement to grant 6.5 million shares at a price of 0.932 pence per share by way of a private placement. Red Rock Resources is another faller after it raised GBP360,000 by placing 77 million shares at 0.47 pence each. The proceeds of the placing will be put towards repayments and working capital. Corero Network Security is down after the network security provider said it expects its Ebitda loss to widen for 2013.

--------

AFTERNOON WATCHLIST: US Redbook Index, IMF Global Growth Forecasts

--------

Wednesday's Key UK Corporate Events

JD Wetherspoon Trading statement
Optos Interim Management Statement
BHP Billiton December Quarter Production, Exploration, Development Report
Hochschild Mining Production Report
Land Securities Group Interim Management Statement
Noble Corporation Q4 Results
Sage Group Interim Management Statement
London Mining Production Report
Findel Interim Management Statement

-------

Wednesday's Key Economic Events

All Day World Economic Forum - Davos
03:00 Japan BoJ Interest Rate Decision
09:30 UK Bank of England Minutes
09:30 UK ILO Unemployment Rate
09:30 UK Public Sector Net Borrowing
12:00 US MBA Mortgage Applications

-------

By Steve McGrath; steve.mcgrath@alliancenews.com; @stevemcgrath1

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.